Portfolio News
Sofinnova Capital & Sofinnova MD Start
Corwave- Start-up & Co - BFM 04/01/2017
Corwave- Start-up & Co - BFM 04/01/2017
Related Company
CorWaveRelated Strategy
CapitalRelated Strategy
MD StartRelated Deal lead
Antoine PapiernikRelated Deal lead
Anne Osdoithttps://www.dailymotion.com/video/x57g8ho_start-up-co-corwave-la-start-up-developpe-une-pompe-cardiaque-04-01_news
Related News
Bionyra Pharma Announces First Healthy Volunteers Dosed in Phase 1 Study of BYN-001, a Long-Acting IL-25 Antibody for Atopic Dermatitis
NodThera Inc. Changes Name to Rezera Inc. and Announces Ruvonoflast Phase 3 Development Program
ProQR Announces First Participant Dosed in Phase 1 Study of AX-0811 and Virtual Investor and Analyst Educational Event on September 30, 2026
Rezera Announces Ruvonoflast Met its Primary Inflammation Endpoint and Demonstrated Favorable Safety Profile in RESOLVE-1 Phase 2 Clinical Trial
Neurent Medical Secures €25 Million Growth Debt Facility from Claret Capital Partners to Accelerate Commercial Expansion